Hunan Hansen Pharmaceutical Co (SZSE:002412) Total Stockholders Equity : ¥2,193 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Hansen Pharmaceutical Co Total Stockholders Equity?

Hunan Hansen Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥2,193 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hunan Hansen Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥4.36. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hunan Hansen Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.04.

Hunan Hansen Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Hunan Hansen Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Hansen Pharmaceutical Co Total Stockholders Equity Chart

Hunan Hansen Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

1,594.72

1,742.29

1,894.13

1,963.03

2,203.38

Hunan Hansen Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															2,027.43	2,077.59	2,101.27	2,203.38	2,193.30

Hunan Hansen Pharmaceutical Co (SZSE:002412) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hunan Hansen Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2193.302	-	0)	/	503.200
	=	4.36

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hunan Hansen Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(83.135	+	0)	/	2193.302
	=	0.04

Hunan Hansen Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hunan Hansen Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Hansen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Hansen Pharmaceutical Co Ltd (SZSE:002412) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

Silver City Road, Long Ridge Industrial Park, Heshan District, Yiyang City, CHN, 413000

Website

http://www.hansenzy.com

Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.

Executives

Luo Yong Qing	Directors, executives
Liu Zheng Qing	Directors, executives
Liu Ling An	Director
Fu Jian Jun	Executives
Liu Na Xin	Independent director
Liu Hou Yao	Directors, Directors, and Executives
He San Xing	Directors, executives

Hunan Hansen Pharmaceutical Co Headlines

No Headlines